Impact of recent developments in lung cancer on the practice of pathology

Philip T. Cagle, Timothy C. Allen, Eric H. Bernicker, Yimin Ge, Abida Haque, Roberto Barrios

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Landmark events in the field of lung cancer in the past year have the potential to significantly alter the practice of pathology. Three key events are (1) approval of payment for low-dose computed tomography screening for lung cancer, (2) publication of an extensively revised World Health Organization classification of lung cancers, and (3) approval of immunohistochemistry based companion diagnostics by the US Food and Drug Administration. We briefly review these milestones in the context of their impact on the practice of pathology.

Original languageEnglish (US)
Pages (from-to)322-325
Number of pages4
JournalArchives of Pathology and Laboratory Medicine
Volume140
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Lung Neoplasms
Pathology
United States Food and Drug Administration
Publications
Immunohistochemistry
Tomography

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Cagle, P. T., Allen, T. C., Bernicker, E. H., Ge, Y., Haque, A., & Barrios, R. (2016). Impact of recent developments in lung cancer on the practice of pathology. Archives of Pathology and Laboratory Medicine, 140(4), 322-325. https://doi.org/10.5858/arpa.2015-0535-SA

Impact of recent developments in lung cancer on the practice of pathology. / Cagle, Philip T.; Allen, Timothy C.; Bernicker, Eric H.; Ge, Yimin; Haque, Abida; Barrios, Roberto.

In: Archives of Pathology and Laboratory Medicine, Vol. 140, No. 4, 01.04.2016, p. 322-325.

Research output: Contribution to journalArticle

Cagle, PT, Allen, TC, Bernicker, EH, Ge, Y, Haque, A & Barrios, R 2016, 'Impact of recent developments in lung cancer on the practice of pathology', Archives of Pathology and Laboratory Medicine, vol. 140, no. 4, pp. 322-325. https://doi.org/10.5858/arpa.2015-0535-SA
Cagle, Philip T. ; Allen, Timothy C. ; Bernicker, Eric H. ; Ge, Yimin ; Haque, Abida ; Barrios, Roberto. / Impact of recent developments in lung cancer on the practice of pathology. In: Archives of Pathology and Laboratory Medicine. 2016 ; Vol. 140, No. 4. pp. 322-325.
@article{3d79ca2afa9b42f4946d95a00900b274,
title = "Impact of recent developments in lung cancer on the practice of pathology",
abstract = "Landmark events in the field of lung cancer in the past year have the potential to significantly alter the practice of pathology. Three key events are (1) approval of payment for low-dose computed tomography screening for lung cancer, (2) publication of an extensively revised World Health Organization classification of lung cancers, and (3) approval of immunohistochemistry based companion diagnostics by the US Food and Drug Administration. We briefly review these milestones in the context of their impact on the practice of pathology.",
author = "Cagle, {Philip T.} and Allen, {Timothy C.} and Bernicker, {Eric H.} and Yimin Ge and Abida Haque and Roberto Barrios",
year = "2016",
month = "4",
day = "1",
doi = "10.5858/arpa.2015-0535-SA",
language = "English (US)",
volume = "140",
pages = "322--325",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - Impact of recent developments in lung cancer on the practice of pathology

AU - Cagle, Philip T.

AU - Allen, Timothy C.

AU - Bernicker, Eric H.

AU - Ge, Yimin

AU - Haque, Abida

AU - Barrios, Roberto

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Landmark events in the field of lung cancer in the past year have the potential to significantly alter the practice of pathology. Three key events are (1) approval of payment for low-dose computed tomography screening for lung cancer, (2) publication of an extensively revised World Health Organization classification of lung cancers, and (3) approval of immunohistochemistry based companion diagnostics by the US Food and Drug Administration. We briefly review these milestones in the context of their impact on the practice of pathology.

AB - Landmark events in the field of lung cancer in the past year have the potential to significantly alter the practice of pathology. Three key events are (1) approval of payment for low-dose computed tomography screening for lung cancer, (2) publication of an extensively revised World Health Organization classification of lung cancers, and (3) approval of immunohistochemistry based companion diagnostics by the US Food and Drug Administration. We briefly review these milestones in the context of their impact on the practice of pathology.

UR - http://www.scopus.com/inward/record.url?scp=84964027464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964027464&partnerID=8YFLogxK

U2 - 10.5858/arpa.2015-0535-SA

DO - 10.5858/arpa.2015-0535-SA

M3 - Article

C2 - 27028391

AN - SCOPUS:84964027464

VL - 140

SP - 322

EP - 325

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -